Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (476)
Cancellation by sponsor (195)
Cancellation or suspension (77)
Prescription medicine registration (37)
Cancellation for failure to pay annual charge (17)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2024 (73)
2023 (102)
2022 (74)
2021 (76)
2020 (120)
2019 (22)
2018 (69)
2017 (106)
2016 (31)
2015 (36)
2014 (21)
2013 (9)
2012 (5)
2011 (6)
2010 (20)
2009 (5)
2008 (3)
2007 (6)
2006 (7)
2005 (2)
2004 (2)
2003 (4)
2002 (3)
2001 (4)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Results for "[search-keyword]"

Search

Sponsor content

811 result(s) found, displaying 621 to 630

PHARMACY CARE IBUPROFEN INFANT DROPS ibuprofen 40 mg/mL oral suspension bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
AMCAL CETIRIZINE cetirizine hydrochloride 5 mg/5 mL oral solution bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY CARE CETIRIZINE cetirizine hydrochloride 5 mg/5 mL oral solution bottle Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY CARE SKIN IRRITATION CREAM 1% hydrocortisone acetate 10mg/g cream tube Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY CARE IBUPROFEN PLUS CODEINE film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
IMATINIB AN imatinib (as mesilate) 100 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
IMATINIB AN imatinib (as mesilate) 400 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
CIPLA LEVETIRACETAM levetiracetam 500 mg film coated tablet blister pack (223396)

19 October 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA LEVETIRACETAM levetiracetam 500 mg film coated tablet blister pack.
CIPLA LEVETIRACETAM levetiracetam 250 mg film coated tablet blister pack (223398)

19 October 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA LEVETIRACETAM levetiracetam 250 mg film coated tablet blister pack.
CIPLA LEVETIRACETAM levetiracetam 1000 mg film coated tablet blister pack (223397)

19 October 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CIPLA LEVETIRACETAM levetiracetam 1000 mg film coated tablet blister pack.

Pages

First page
Previous page
…
Page 59
Page 60
Page 61
Page 62
Current page 63
Page 64
Page 65
Page 66
Page 67
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.